Skip to main content

Peer Review reports

From: The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study

Original Submission
1 Jul 2023 Submitted Original manuscript
7 Jul 2023 Author responded Author comments - Pei-Rong Ding
10 Jul 2023 Author responded Author comments - Pei-Rong Ding
Resubmission - Version 2
7 Jul 2023 Submitted Manuscript version 2
13 Jul 2023 Author responded Author comments - Pei-Rong Ding
Resubmission - Version 3
13 Jul 2023 Submitted Manuscript version 3
4 Oct 2023 Reviewed Reviewer Report - Ioannis Gkekas
1 Nov 2023 Reviewed Reviewer Report
2 Nov 2023 Reviewed Reviewer Report - Yongjun Cha
12 Dec 2023 Author responded Author comments - Pei-Rong Ding
Resubmission - Version 4
12 Dec 2023 Submitted Manuscript version 4
2 Jan 2024 Reviewed Reviewer Report - Yongjun Cha
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
2 Jan 2024 Editorially accepted
2 Feb 2024 Article published 10.1186/s12885-024-11821-w

You can find further information about peer review here.

Back to article page